<DOC>
	<DOCNO>NCT01239758</DOCNO>
	<brief_summary>To evaluate long-term safety tolerability ACE-031 administration subject Duchenne muscular dystrophy ( DMD ) participate Study A031-03 . [ Note : This study terminate base preliminary safety data . Pending analysis safety data discussion health authority , new ACE-031 trial plan . ]</brief_summary>
	<brief_title>Extension Study ACE-031 Subjects With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Completion participation Study A03103 Investigator approval Continuation corticosteroid therapy absolute dose schedule Study A03103 Participation therapeutic clinical trial Plans surgery course study</criteria>
	<gender>Male</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>